Park et al. demonstrated that phosphorylation of p70S6K activation was inhibited secondary to melatonin treatment, which resulted in decreased HIF-1α expression in DU145, PC3, and LNCaP prostate cancer cell lines. The gene discussed is HIF1A; the disease is Familial prostate cancer.